Menopause Care, Reconsidered: Clinical Insights from a Recent Menopause Society Symposium
Menopause is not a pathology—it is a natural, complex, and deeply individualized life transition. Yet the way it is currently marketed and treated often tells a different story.
After attending a recent Menopause Society symposium, one theme stood out clearly: there is a widening gap between evidence-based care and commercially driven solutions. While innovation in women’s health is welcome, there is reason to be discerning—particularly when care models begin to resemble sales platforms.
A Note on Care Models
There is growing concern around direct-to-consumer menopause platforms that blur the line between treatment and product sales. Menopause care is best delivered through accountable, medically supervised providers who prioritize individualized assessment, longitudinal care, and clinical integrity.
Understanding FSH: Context Matters
Follicle-stimulating hormone (FSH) is often used in discussions of fertility and menopause—but interpretation requires nuance.
FSH levels fluctuate based on:
Cycle timing
Age
Lab-specific reference ranges
For women, typical ranges include:
Day 3 (follicular phase): ~2.5–10 mIU/mL
Ovulatory phase: ~3–33 mIU/mL
Luteal phase: ~1–9 mIU/mL
Postmenopause: >25 mIU/mL
Clinically:
<10 mIU/mL → optimal fertility range
10–15 → borderline ovarian reserve
15–20 → possible diminished reserve
FSH naturally rises as menopause approaches, but a single value is rarely diagnostic in isolation.
Menopausal Hormone Therapy (MHT): A Balanced View
Hormone therapy has evolved significantly.
Earlier formulations (e.g., estrogen without adequate progesterone) were associated with increased endometrial cancer risk. Current approaches are more refined and guided by what is often referred to as a “window of safety”—typically before age 60 or within 10 years of menopause onset.
Potential Benefits
Reduction in hot flashes
Improved sleep
Stabilization of mood
Risks to Consider
Stroke
Blood clots
Slight increase in breast cancer risk
Best Practice Approach
Begin with behavioral and symptom-based strategies
Track symptoms consistently (mood, energy, cognition)
Introduce MHT when clinically appropriate
Favor transdermal delivery (patches, creams), which carry lower risk than oral estrogen
Allow ~6 months for full therapeutic effect
Red Flags in Care
Estrogen presented as a “cure-all”
Providers selling proprietary products
Claims that progesterone cream alone is sufficient
Mood, Libido, and Behavioral Interventions
Hormonal shifts can significantly impact mood and sexual health.
Bupropion may support both mood and libido in select cases
Behavioral activation remains first-line
Intentional intimacy, including increased foreplay and communication, is essential
Awareness of emotional and physiological triggers improves outcomes
Genitourinary Syndrome of Menopause (GSM)
Previously termed vaginal atrophy, GSM is both common and treatable.
Symptoms
Vaginal dryness and irritation
Microbiome changes
Recurrent urinary tract infections
Effective Interventions
Vaginal estrogen therapy
DHEA
Pelvic floor exercises (daily Kegels)
High-quality lubricants (silicone-based preferred)
Avoid:
Coconut oil
Harsh soaps or irritants
Hygiene Recommendations
Use gentle cleansers (e.g., Cetaphil)
Avoid antibacterial soaps that disrupt natural flora
Exercise as Medicine
Movement is a cornerstone of menopausal health.
150 minutes/week light aerobic activity (e.g., walking)
or75 minutes/week moderate activity (e.g., jogging)
Strength training 2x weekly for bone and muscle preservation
For joint discomfort:
Yoga
Tai chi
Low-impact, weight-bearing exercise
Nutrition & Lifestyle Foundations
Dietary patterns play a critical role in symptom management and long-term health.
Prioritize:
Whole grains
Fruits and vegetables
Fiber (~25g/day)
Omega-3 fatty acids
Incorporate phytoestrogens:
Soy
Flaxseed
Legumes
Reduce:
Ultra-processed foods
Supplements: A Food-First Philosophy
When needed, supplementation may support overall health:
Calcium
Vitamin D
Vitamin B12
Omega-3s
Magnesium (with physician guidance)
Magnesium Highlights
Supports mood, sleep, and stress regulation
Forms matter:
Glycinate → calming
L-threonate → cognitive support
Taurate → cardiovascular support
Citrate → effective but may be laxative
Typical dosing ranges from 200–400 mg daily, depending on individual needs.
Sleep Support
Sleep disruption is one of the most common complaints during menopause.
Helpful supports include:
Melatonin
Valerian root
Consistent sleep hygiene practices
Psychosocial Health: Often Overlooked, Always Essential
Menopause is not just biological—it is psychological and social.
Protect and prioritize:
Social connection
Restorative rituals (reading, baths, time with friends)
Meaningful, identity-affirming activities
A Grounded Perspective
Menopause is a transformative stage marked by physical, emotional, and cognitive shifts. It is not something to “fix,” but something to navigate with precision and care.
The most effective approach is:
Individualized
Gradual
Evidence-based
And importantly—free from unnecessary commercialization.
Recommended Reading
The Menopause Manifesto
The New Menopause by Dr. Mary Claire Haver
If you’d like, this can be adapted into a one-page patient handout or a more technical clinician brief for practice use.
